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Pulmonary hypertension (PH) is a condition that refers to a
mean pulmonary artery pressure of at least 25 mmHg mea-
sured by right heart catheterisation at rest. PH is classified
in five groups based on the underlying clinical condition [1].
Some of these conditions are orphan diseases and managed
in designed tertiary PH centres with dedicated multidisci-
plinary teams. During the last decades great progress has
been made on the epidemiology, aetiology, pathophysiol-
ogy and treatment of PH. Some of these efforts were mainly
based on national PH registries, first published in the early
1980 s [2]. The primary goal of these clinical observational
PH registries is to describe patients with PH and the impact
of this disease [3]. Until recently, no such a national PH
registry was available in the Netherlands.
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In 2012, the Dutch multidisciplinary multicentre registry
for PH (PulmoCor) was initiated by three tertiary PH cen-
tres and supported by the Interuniversity Cardiology In-
stitute of the Netherlands (ICIN). Nowadays, six tertiary
PH centres participate in this program (5 university medi-
cal centres and 1 non-university hospital). A working group
including PH specialists (both cardiologists and pulmonolo-
gists) of all participating centres was established and regu-
lations for this project have been drawn up. Several privacy-
enhancing technologies have been used in accordance with
the Dutch Privacy protections laws for data collection.
The aims of the PulmoCor registry are to further op-
timise patient care and research in the field of PH, and
the joint collaboration between the national and interna-
tional PH centres. Interestingly, the same structured web-
based PH database, specially developed for the management
of PH patients (PAHtool, Inovolutus, Portugal), is used in
other international PH centres as well, both European and
non-European [4]. The PulmoCor registry will facilitate in-
vestigation of the epidemiology of specific subtypes of PH,
the treatment and long-term outcome. It will increase the
awareness of this rare disease throughout the Netherlands.
Furthermore, the registry can be used as clinical database
as well.
Based on the current international guidelines, all PH cen-
tres used a standardised diagnostic approach for PH analysis
[1]. Different data regarding the initial work-up and follow-
up could be included in the PulmoCor registry. Each partic-
ipating PH centre is using the secured uniformly structured
database for the registration of their patients and these data
are only accessible by this centre. To date, a total of 1493
patients with pulmonary hypertension (both prevalent and
incident cases) have been included in the PulmoCor reg-
istry. In Fig. 1, this total group is shown according to the
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Fig. 1 Total number of patients with pulmonary hypertension in-
cluded in the PulmoCor registry divided by clinical classification (a)
and the subgroup of pulmonary arterial hypertension (b). Group 1
Pulmonary arterial hypertension; Group 2 PH due to left heart dis-
ease; Group 3 PH due to lung disease and/or hypoxia; Group 4
Chronic thromboembolic PH and other pulmonary artery obstruc-
tions; Group 5 PH with unclear and/or multifactorial mechanisms
[1]. (CTD connective tissue disease, HIV human immunodeficiency
virus, CHD congenital heart disease, PVOD pulmonary veno-occlusive
disease, PCH pulmonary capillary haemangiomatosis)
clinical classification (a) and the subgroup of patients with
pulmonary arterial hypertension (PAH), group 1 (b).
The uniformly designed PulmoCor registry data acqui-
sition will increase the value of national collaboration both
clinically and scientifically.
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